IRadimed Corporation
IRMD
$72.69
$1.191.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.77M | 4.69M | 5.15M | 5.05M | 4.90M |
| Total Depreciation and Amortization | 207.50K | 194.10K | 194.90K | 197.60K | 199.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 309.20K | 1.49M | 433.40K | 743.30K | -899.80K |
| Change in Net Operating Assets | 1.46M | -2.08M | 212.10K | 3.13M | 2.44M |
| Cash from Operations | 7.75M | 4.29M | 5.99M | 9.12M | 6.64M |
| Capital Expenditure | -2.64M | -3.70M | -2.79M | -3.81M | -1.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -188.00K | -219.80K | -266.60K | -201.50K | -135.50K |
| Cash from Investing | -2.82M | -3.92M | -3.06M | -4.01M | -1.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 26.30K | 0.00 | 3.30K |
| Repurchase of Common Stock | -96.00K | -116.30K | -542.50K | -17.80K | -63.90K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.16M | -2.16M | -1.90M | -1.90M | -1.90M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.26M | -2.28M | -2.42M | -1.92M | -1.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.66M | -1.90M | 512.90K | 3.19M | 3.41M |